
* Includes only unique trials
Basic Summary : Apixaban
* Includes only unique trials
* Highest Phase based on Product+Indication
* List the top 8 Indication
* Criteria based on Product+Indication
*Display Highest Phase based on Product & Indication.
* List the top 8 Therapeutic Area
* Criteria based on Product
*Display total no of trials.
* List the top 8 Sponsors
* Criteria based on Product
* Based on
Product,Indication.
* Next Ten year projection only.
* Products listed based on Indication
Country | Trial Id | Start Date | Completion Date | Study Title | Product | Primary Product | Synonym | Product Type | Biological Class (If any) | Industry Type | Biomarker/MOA | Indication | Therapeutic Area | Original Trial Phase | Current Development Phase | Marketing Status | Trial Status | Prediction Of Launch | Patent Expiry Date | Sales Data ($ MN) 2023 | Terminated Reason | Outcome Measures | Clinical Trial Result | Sponsor/Collaborator | Primary Sponsor | Sponsor Type | Sponsor Classification | Probable Licensing Opportunity | Expedited Program | Contact Details | Gender | Age | Population Size | Study Design | Study Type | First Posted | Results First Posted | Last Update Posted | Location |
---|